Article
AMO acquires IntraLase
The acquisition of IntraLase Corp. by Advanced Medical Optics (AMO), announced Jan. 9, joins two of the strongest performers in the refractive surgery market. The $808 million cash transaction may be the impetus for a change in how the traditional microkeratome is viewed among refractive surgeons.
Related Videos
Related Content
Published: October 12th 2024 | Updated: October 11th 2024
First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial
